Template:Hormone levels with transdermal estradiol gel
Jump to navigation
Jump to search
Template documentation
- Hormone levels with transdermal estradiol gel
Levels of estradiol and estrone with once daily application of 1.25 g of a transdermal estradiol gel (EstroGel) containing 0.06% or 0.75 mg estradiol after 14 days of continuous therapy in postmenopausal women.[1]
Estradiol levels after the last dose with 1 mg/day transdermal estradiol gel applied to different amounts of skin area (200 cm2, 400 cm2, or as large as possible) in postmenopausal women.[4]
See also
References
- ↑ "EstroGel® 0.06% (Estradiol Gel) for Topical Use FDA Label" (PDF). Food and Drug Administration. 2017. Retrieved 22 July 2018.
- ↑ Potts RO, Lobo RA (May 2005). "Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist". Obstet Gynecol. 105 (5 Pt 1): 953–61. doi:10.1097/01.AOG.0000161958.70059.db. PMID 15863530.
- ↑ Scott RT, Ross B, Anderson C, Archer DF (May 1991). "Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol". Obstet Gynecol. 77 (5): 758–64. doi:10.1016/0020-7292(92)90761-7. PMID 2014092.
- ↑ Järvinen A, Granander M, Nykänen S, Laine T, Geurts P, Viitanen A (November 1997). "Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing". Br J Obstet Gynaecol. 104 Suppl 16: 14–8. doi:10.1111/j.1471-0528.1997.tb11562. PMID 9389778.
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |